SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-22-003629
Filing Date
2022-02-24
Accepted
2022-02-24 07:02:35
Documents
107
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vnda-20211231.htm   iXBRL 10-K 2236812
2 EX-4.2 vnda1231202110-kexhibit42.htm EX-4.2 23064
3 EX-10.12 vnda12312021ex10122014path.htm EX-10.12 470039
4 EX-10.29 vnda12312021ex10292016path.htm EX-10.29 406198
5 EX-23.1 vnda12312021ex231.htm EX-23.1 2391
6 EX-31.1 vnda12312021ex311.htm EX-31.1 10766
7 EX-31.2 vnda12312021ex312.htm EX-31.2 10616
8 EX-32.1 vnda12312021ex321.htm EX-32.1 6782
14 vnda-20211231_g1.gif GRAPHIC 4652
15 vnda-20211231_g2.jpg GRAPHIC 21579
16 vnda-20211231_g3.gif GRAPHIC 3959
17 vnda-20211231_g4.jpg GRAPHIC 51193
18 vnda-20211231_g5.jpg GRAPHIC 185957
  Complete submission text file 0001628280-22-003629.txt   10815622

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vnda-20211231.xsd EX-101.SCH 65478
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vnda-20211231_cal.xml EX-101.CAL 97867
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vnda-20211231_def.xml EX-101.DEF 248776
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vnda-20211231_lab.xml EX-101.LAB 731194
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vnda-20211231_pre.xml EX-101.PRE 492772
101 EXTRACTED XBRL INSTANCE DOCUMENT vnda-20211231_htm.xml XML 1473969
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34186 | Film No.: 22666470
SIC: 2834 Pharmaceutical Preparations